Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

SVA
Sinovac Biotech, Ltd
stock NASDAQ

Inactive
Feb 22, 2019
6.47USD-0.308%(-0.02)8,227
Pre-market
0.00USD-100.000%(-6.49)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
01:13PM EST  New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 Bamboo Works Special Report   Benzinga
Jan 24, 2022
12:44PM EST  Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows   Benzinga
Jan 10, 2022
09:47AM EST  IIROC Trading Resumption - SVA   PR Newswire
09:42AM EST  IIROC Trading Halt - SVA   PR Newswire
Jan 3, 2022
07:23AM EST  Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters   Benzinga
Dec 30, 2021
04:09PM EST  SINOVAC Reports Unaudited First Half 2021 Sales Results Of $11B, Up From $67.7M YoY   Benzinga
04:05PM EST  SINOVAC Reports Unaudited First Half of 2021 Financial Results   Business Wire
Dec 23, 2021
05:12AM EST  Three Sinovac Doses Fail to Protect Against Omicron in Study   Benzinga
Dec 9, 2021
02:26PM EST  Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment   Business Wire
Dec 3, 2021
11:21AM EST  Sinovac Says Beijing Settled Litigation Of Its Business License And Seals BZ NOTE: Shares Of Sinovac Have Not Traded In Over A Year   Benzinga
11:20AM EST  SINOVAC Beijing Settled Litigation of Its Business License and Seals   Business Wire
Nov 9, 2021
11:33AM EST  Preliminary Results Show SINOVAC's COVID-19 Vaccine Demonstrates Good Safety Profile Among The Pediatric And Adolescent Population   Benzinga
07:49AM EST  SINOVAC Biotech Ltd. (SVA) on Tuesday said preliminary data from the Phase 3 study showed that the company's Covid-19 vaccine candidate, CoronaVac is safe for healthy people in the pediatric and adolescent population of 3 to 17 years of age.   RTTNews
07:07AM EST  SINOVAC Biotech Announces New Preliminary Data On Inactivated COVID-19 Vaccine CoronaVac   RTTNews
07:00AM EST  Preliminary Results Show SINOVAC's COVID-19 Vaccine Demonstrates Good Safety Profile Among the Pediatric and Adolescent Population   Business Wire
Sep 24, 2021
09:16AM EDT  Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters   Benzinga
Sep 9, 2021
08:17AM EDT  The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization   Benzinga
06:07AM EDT  New Research On SINOVAC's COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including The Delta Variant   Benzinga
06:05AM EDT  Sinovac Biotech Reports New Research On COVID-19 Vaccine Shows Third Dose More Effective   RTTNews
06:00AM EDT  New Research on SINOVAC's COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant   Business Wire
Sep 8, 2021
05:50PM EDT  Chinese biopharmaceutical company Sinovac Biotech Ltd. (SVA) said on Wednesday that CoronaVac, an inactivated COVID-19 vaccine developed by its subsidiary, Sinovac Life Sciences Co. Ltd., has received approval from the Public Health Institute of Chile for emergency use in children and adolescents aged between 6 and 17.   RTTNews
04:23PM EDT  SINOVAC Announces COVID-19 Vaccine Approved For Emergency Use In Chile For Children And Adolescents   RTTNews
Aug 10, 2021
07:10AM EDT  SINOVAC Announces Positive Data on Booster Shots of CoronaVac, Induces Strong Immune Response in Adult and Elderly Populations   Benzinga
07:05AM EDT  SINOVAC Announces Positive Data On Booster Shots Of CoronaVac   RTTNews
07:00AM EDT  SINOVAC Announces Positive Data on Booster Shots of CoronaVac(r), Induces Strong Immune Response in Adult and Elderly Populations   Business Wire
Aug 9, 2021
08:22AM EDT  INOVIO Expands Partnership With Advaccine To Explore   RTTNews
Jul 20, 2021
02:32PM EDT  EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine   Benzinga
Jul 19, 2021
07:40AM EDT  SINOVAC Biotech Ltd. (SVA) said Monday it received a drug registration approval from the National Medical Product Administration of China or "NMPA" for its Sabin strain based inactivated polio vaccine or "sIPV".   RTTNews
07:08AM EDT  SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine To Support Global Polio Endgame Strategy   Benzinga
07:07AM EDT  SINOVAC Gets Drug Registration Approval From China NMPA For Sabin Strain Based Inactivated Polio Vaccine   RTTNews
07:02AM EDT  SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine (sIPV) to Support Global Polio Endgame Strategy   Business Wire
Jul 16, 2021
08:59AM EDT  Lancet Study Shows BioNTech COVID-19 Vaccine Generates 10X Higher Antibody Levels Compared to Sinovac Shot   Benzinga
Jul 12, 2021
06:03AM EDT  Chinese biopharmaceutical company Sinovac Biotech Ltd. (SVA) announced Monday that it had signed an advance purchase agreement or APA with Gavi, the Vaccine Alliance, to supply up to 380 million doses of inactivated COVID-19 vaccine, CoronaVac, for distribution through the COVAX Facility.   RTTNews
05:45AM EDT  Sinovac Biotech Signs APA With Gavi For 380 Mln Doses Of CoronaVac Through COVAX Facility   RTTNews
05:40AM EDT  SINOVAC Enters Into Agreement to Supply CoronaVac(r) to COVAX   Business Wire
Jun 30, 2021
06:36AM EDT  Sinovac: The Lancet Infectious Diseases Publishes Results From Phase I/II Trials Of COVID-19 Vaccine CoronaVac   RTTNews
06:33AM EDT  Sinovac Highlights Publication Of Phase I/II COVID-19 Study In The Lancet Infectious Diseases   Benzinga
06:30AM EDT  The Lancet Infectious Diseases Published Data from Sinovac's Phase I/II Study, World's First Published Study on Clinical Trial Results of a COVID-19 Vaccine in Healthy Children and Adolescents Aged 3 to 17 Years Old   Business Wire
Jun 2, 2021
07:52AM EDT  Chinese biopharmaceutical company Sinovac Biotech Ltd. (SVA) announced that CoronaVac, an innovative, inactivated coronavirus vaccine developed by its subsidiary Sinovac Life Sciences Co., Ltd., was approved for emergency use under the World Health Organization Emergency Use Listing (EUL) procedure.   RTTNews
07:38AM EDT  SINOVAC Biotech: WHO Authorizes Coronavirus Vaccine CoronaVac For Emergency Use   RTTNews
07:32AM EDT  SINOVAC Biotech Ltd Announces The World Health Organization Authorized The Company's CoronaVac for Emergency Use   Benzinga
07:30AM EDT  World Health Organization Authorizes SINOVAC's CoronaVac(r) for Emergency Use   Business Wire
Jun 1, 2021
10:36AM EDT  WHO Approved Emergency Use Listing For COVID-19 Vaccine Made By Chinese Drug Maker Sinovac   Benzinga
May 25, 2021
08:05AM EDT  Sanofi, Walvax COVID-19 Vaccine Phase 3 Trials to Commence in Mexico: Reuters   Benzinga
Apr 22, 2021
07:54PM EDT  Sinovac Biotech Q4 EPS $0.96 Vs. $0.20 Year Ago   RTTNews
07:05PM EDT  Sinovac Biotech Ltd. (SVA) announced earnings for its fourth quarter that rose from last year.   RTTNews
06:51PM EDT  Sinovac Reports Unaudited Fourth Quarter 2020 Financial Results and Files 2020 Annual Report on Form 20-F   Business Wire
Apr 1, 2021
11:49PM EDT  Sinovac Announces Third Production Line Of CoronaVac Completed And Put Into Commercial Production   RTTNews
11:30PM EDT  Sinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 Vaccine   Business Wire
Mar 29, 2021
08:35AM EDT  Life Sciences Investor Forum today announced that the presentations from the March 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.   GlobeNewswire Inc
Mar 22, 2021
10:36AM EDT  Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a leading clinical-stage company focused on developing regenerative medicine therapeutics company, today announcedthat Dr. Philip Toleikis, President and CEO will present live at LifeSciencesInvestorForum.com on March 25th.   GlobeNewswire Inc
Mar 19, 2021
08:35AM EDT  Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.   GlobeNewswire Inc
Mar 8, 2021
12:16PM EST  Sinovac COVID-19 Vaccine Prelim Data Shows Is Effective Against Brazilian P1 Variant; BZ NOTE: Sinovac Shares Do Not Currently Trade In US   Benzinga
07:09AM EST  Philippines, Moderna Reach 13M Vaccine Doses Supply Pact   Benzinga
Feb 22, 2021
04:05PM EST  Sinovac Amends Shareholder Rights Plan   Business Wire
Feb 17, 2021
05:12PM EST  Sinovac Vaccine Works On The UK And South African Strains   Benzinga
Feb 16, 2021
06:38AM EST  Hong Kong Advisory Panel Approves China's Sinovac Covid-19 Vaccine for Emergency Use   Benzinga
Feb 8, 2021
07:57AM EST  Sinovac Biotech Ltd. (SVA) said Monday that it has received a conditional marketing authorization in China for its COVID-19 vaccine.   RTTNews
07:33AM EST  Sinovac: China NMPA Grants Conditional Marketing Authorization For Its COVID-19 Vaccine   RTTNews
07:30AM EST  Sinovac Says Receives Conditional Marketing Authorization In China For COVID-19 Vaccine   Benzinga
07:30AM EST  Sinovac Receives Conditional Marketing Authorization in China for its COVID-19 Vaccine   Business Wire
Feb 5, 2021
04:19PM EST  Sinovac Announces Phase III Results Of Its COVID-19 Vaccine   RTTNews
04:08PM EST  Sinovac Announces The Results For Its Phase 3 Coronavirus Vaccine; Co. Says A Total Of 25K Patients Have Enrolled Across 4 Countries   Benzinga
04:05PM EST  Sinovac Announces Phase III Results of Its COVID-19 Vaccine   Business Wire
Feb 4, 2021
09:59AM EST  IIROC Trading Resumption - SVA   PR Newswire
09:37AM EST  IIROC Trading Halt - SVA   PR Newswire
Feb 3, 2021
09:59AM EST  Sinovac Biotech Ltd. (SVA) said Wednesday that it has filed for conditional market authorization for its COVID-19 vaccine, CoronaVa, with China's National Medical Products Administration.   RTTNews
09:55AM EST  SinoVac Files For Conditional Market Authorization Of COVID-19 Vaccine In China; Says Preliminary Results Of Trials Demonstrated A Good Safety Profile For Vaccine   Benzinga
09:54AM EST  Sinovac Files For Conditional Market Authorization Of COVID-19 Vaccine In China   RTTNews
Feb 2, 2021
08:32AM EST  UPDATE: Cassava Sciences Says Results Support Advancing Simufilam Into Phase 3 Clinical Program   Benzinga
Jan 20, 2021
10:29AM EST  WHO Doc Shows Expectation For Approval Of COVID-19 Vaccines In China By Sinopharma, Sinovac In Mar. At Earliest   Benzinga
Jan 15, 2021
02:45PM EST  IIROC Trading Resumption - SVA   PR Newswire
02:28PM EST  IIROC Trading Halt - SVA   PR Newswire
Jan 12, 2021
11:05AM EST  'Sinovac's #COVID19 #vaccine is 100% effective in preventing severe and moderate infections, 78% effective in preventing mild cases, and has an overall efficacy of 50.4%, in Brazil's final-stage trials...'   Benzinga
Jan 11, 2021
03:53PM EST  China's CoronaVac Vaccine Has A General Efficacy Of Less Than 60% In Brazilian Trial   Benzinga
Jan 7, 2021
10:08AM EST  Sauo Paulo's Butantan Institute Submitted Request For Emergency Use Of COVID-19 Vaccine Made By China's Sinovac   Benzinga
09:21AM EST  Late Stage Trial Of Sinovac COVID-19 Vaccine In Brazil Shows Efficacy Of 78%   Benzinga
Dec 28, 2020
05:06AM EST  Wuhan Launched Emergency Covid-19 Vaccinations for Key Groups According to Local CDC Official   Benzinga
Dec 24, 2020
11:45AM EST  Turkish Researchers Say One Serious Side-Effect Was Seen During China's CoronaVac Trials, As One Person Became Allergic   Benzinga
Dec 23, 2020
01:22PM EST  UPDATE: Efficacy Of Sinovac's Coronavac Vaccine Candidate Above 50% In Trials   Benzinga
01:20PM EST  State Of Sao Paulo In Brazil Says Will No Longer Release Results Of Sinovac's COVID-19 Vaccine Today   Benzinga
04:07AM EST  1Globe Capital LLC (1GlobeCap), a principal and long-term shareholder of Sinovac Biotech (NASDAQ: SVA) (Sinovac), has reached agreement with the Securities and Exchange Commission (SEC) to end investigation of its 13D form compliance.   GlobeNewswire Inc
Dec 22, 2020
09:27AM EST  CDH Utopia Limited Reports In 13D Filing An 8.44% Stake In Sinovac Biotech   Benzinga
Dec 21, 2020
03:11PM EST  'Brazil Poised to Announce Phase 3 Trial Results of Sinovac Covid-19 Vaccine on Dec. 23' -Dow Jones   Benzinga
03:10PM EST  'China's Sinovac Vaccine Shown To Be Effective Against Covid-19 In Brazil Trials, Sources Say' -Dow Jones   Benzinga
Dec 9, 2020
07:51AM EST  Sinovac Biotech Ltd. (SVA), a China-based biopharmaceutical company, said Wednesday that the China National Medical Products Administration or NMPA has approved and issued a product license for the company's 23-Valent Pneumococcal Polysaccharide or PPV Vaccine to prevent the infection by streptococcus pneumonia in adults and children aged 2 years old and above.   RTTNews
07:35AM EST  Sinovac Announces China NMPA Approves Product License For 23-Valent Pneumococcal Polysaccharide Vaccine   RTTNews
07:31AM EST  Sinovac Biotech Reports China National Medical Products Admin. Approved, Issued Product License For Co.'s 23-Valent Pneumococcal Polysaccharide Vaccine To Prevent Infection By Streptococcus Pneumonia In Adults   Benzinga
07:30AM EST  Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine   Business Wire
Dec 7, 2020
07:42AM EST  Sinovac Biotech Ltd. (SVA) announced a profit for its third quarter that increased from last year.   RTTNews
07:35AM EST  Sinovac Biotech Q3 EPS $0.10 Down From $0.19 YoY, Sales $115.50M Up From $64.30M YoY   Benzinga
07:34AM EST  Sinovac Q3 EPS $0.10 Vs $0.06 Last Year   RTTNews
07:30AM EST  Sinovac Reports Unaudited Third Quarter 2020 Financial Results   Business Wire
06:59AM EST  Sinovac Secures ~$500M in Funding for COVID-19 Vaccine Development   Benzinga
12:02AM EST  Sinovac Biotech Ltd. (SVA), a China-based biopharmaceutical company, announced that its unit Sinovac Life Sciences Co., Ltd. or Sinovac LS has secured around $500 million in funding for COVID-19 Vaccine development.   RTTNews
Dec 6, 2020
06:30PM EST  Sinovac Secures Approximately $500 Million in Funding for COVID-19 Vaccine Development   Business Wire
Nov 10, 2020
09:22AM EST  Brazil's Sao Paulo Health Secretary Says Sinovac Trial Volunteer Died From 'External Cause'   Benzinga
Oct 19, 2020
12:04PM EDT  Director For Brazilian Biologic Research Center, Butantan Institute, Says, Following Trials On 9K Volunteers, Sinovac Vaccine Viewed As 'Safe'   Benzinga
11:52AM EDT  Sao Paulo Governor Doria Says Vaccine by China's Sinovac Proves Safe In First Clinical Tests In Brazil And Is Most Promising To Fight Coronavirus   Benzinga
Sep 28, 2020
08:56AM EDT  Sinovac Biotech Ltd. (SVA) said Monday that the Fourth Intermediate People's Court of Beijing issued a judgement holding Sinobioway Bio-medicine Co., Ltd. and Mr Aihua Pan or collectively, "the Defendants" liable for torts and breaches of shareholder fiduciary duty.   RTTNews
08:37AM EDT  Beijing Court Issues Judgement Against Sinobioway And Aihua Pan Liable For Torts And Breaches Of Shareholder Duty   RTTNews
08:30AM EDT  Beijing Fourth Intermediate People's Court Issues Judgement Against Sinobioway Medicine and Mr. Aihua Pan   Business Wire
Sep 23, 2020
08:36AM EDT  Sinovac Announces NMPA Approval Of Clinical Trial For Coronavac SARS-CoV-2 Vaccine In Adolescents and Children   Benzinga
08:30AM EDT  Sinovac's Coronavac(tm), SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children   Business Wire
Sep 22, 2020
08:31AM EDT  Sinovac Biotech Ltd. (SVA), a provider of biopharmaceutical products in China, said Tuesday it has recently commenced Phase III clinical trials for its inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences, or "CoronaVac," in Turkey.   RTTNews
08:03AM EDT  Sinovac Biotech Recently Commences Phase III Clinical Trials For Its Inactivated COVID-19 Vaccine Candidate In Turkey   RTTNews
08:02AM EDT  Sinovac Commences Phase III Clinical Trials For COVID-19 Vaccine Candidate In Turkey   Benzinga
Sep 9, 2020
12:50PM EDT  UPDATE: Sinovac Says Coronavirus Vaccine Candidate 'shows good safety and immunogenicity on healthy adults aged 60 and above from its phase I/II clinical studies conducted in China'   Benzinga
12:49PM EDT  Sinovac Biotech Offers Prelim. Phase 1/2 Results Of Coronavirus Vaccine In Elderly Volunteers   Benzinga
12:48PM EDT  Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in Elderly Volunteers   Business Wire
12:06PM EDT  Sao Paulo Governor Says Until Now, Phase 3 Trials Of Potential Sinovac Vaccine Has Shown Promising Results; Says vaccine May Be Available To Brazil's Population As Early As December   Benzinga
Sep 6, 2020
08:45AM EDT  Sinovac CEO Yin Weidong Says 90% of Company Employees, Families Took Coronavirus Vaccine   Benzinga
Aug 28, 2020
04:37PM EDT  Sinovac Biotech Q2 Loss/share $0.05 Vs. Profit $0.11 Year Ago   RTTNews
04:16PM EDT  Sinovac Biotech Q2 Adj. EPS $(0.04) Down From $0.12 YoY, Sales $52.30M Down From $64.05M YoY   Benzinga
04:15PM EDT  Sinovac Reports Unaudited Second Quarter 2020 Financial Results   Business Wire
Aug 25, 2020
08:34AM EDT  Sinovac Biotech Signs Two Agreements In Hainan, China With PT Bio Farma   RTTNews
08:33AM EDT  Sinovac Signs Agreement With Bio Farma Indonesia For COVID-19 Vaccine Cooperation   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC